Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Gossamer Bio Inc. (GOSS) Misses Q1 EPS by 7c
May 12, 2020 4:26 PM EDTGossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.87), $0.07 worse than the analyst estimate of ($0.80).
We are very pleased today to share initial results of the Gossamer teams great execution and hard work, including that we have successfully completed the interim analysis of the LEDA study of GB001, said Sheila Gujrathi, M.D., Co-Founder and Chief Executive Officer of Gossamer. We have begun initial Phase 3 planning and supportive activities, while awaiting final... More
